CD47 and glioblastoma: Our results demonstrated a pronounced correlation between αvβ3 and CD47 surface expression in the majority of tumor‐derived lines (R2 = 0.830, p < 0.001; Figure1A), including those of colorectal, lung, glioblastoma, and breast origin.